The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
How are leading firms redefining their competitive advantage in electronic fixed income trading? Explore the next frontier ...
Natera delivers robust revenue growth, raising 2026 guidance to $2.74–$2.82 billion, but remains unprofitable. Read more on ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Kardigan’s offering proposes 23.3 million shares at $14–$16, targeting ~$350 million gross proceeds and an implied ~$1.3 billion valuation amid a reopened biotech IPO window. Danicamtiv, an oral ...
Abstract: Accurate stock prediction is a pressing challenge in quantitative finance, where complex temporal and cross-sectional dynamics defy traditional models. Although deep learning-based methods ...
Abstract: We present a novel genetic programming (GP) algorithm that combines physical time and event-based time indicators to trade on the stock market. Rather than only using data in fixed intervals ...
Users of PayPal Holdings (PYPL) Venmo can now send and receive money from PayPal users across 90 markets, marking the largest expansion of Venmo's addressable market since the app's launch, the ...
Rhythm Pharmaceuticals ( (RYTM)) has provided an update. On December 16, 2025, Rhythm Pharmaceuticals announced that board member Camille L. Bedrosian, M.D. resigned from the company’s Board of ...
Drug giant Eli Lilly is launching an AI-powered drug discovery platform. While it won't generate any revenue, this initiative could pay off in the long run. Still, there are plenty of other reasons to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results